HEPA | Hepion PharmaceuticalsCompany profile
Company ProfileHepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV).
Address399 Thornall Street | NotesResearchInvestor pagehepionpharma.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended BooksBuy on Amazon In the world of investing, slow and steady wins the race. With this mantra in mind, trusted author and finance guru Eric Tyson is back with the latest edition of the #1 bestselling book, Investing For Dummies, to help you achieve your investment goals. |